glp-1 chronic kidney disease Design and discovery of a highly potent ultralong-acting and glucagon co-agonist for attenuating renal fibrosis Glucagon-like Peptide Receptor Agonists and

The duration varies significantly depending on which medication you use

GLP1-RAs are commonly used as a weight loss drug and side effects may include gastrointestinal issues such as nausea, vomiting, diarrhea, constipation and abdominal pain

Aim for at least 8 glasses of water per day and consider adding electrolytes

Exendin-4 has been shown to act on the Wnt/-catenin pathway in osteoblasts via the GLP-1R, thereby promoting bone formation and reducing sclerostin levels in T2DM rats (Kim et al., 2013)

The latest formulationsthe Wegovy pill and orforglipron (Foundayo)have shown comparable results to injectables in recent clinical trials